EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in antimicrobial peptide-based therapy

Aditya Mulukutla, Romi Shreshtha, Vishal Kumar Deb, Pallabi Chatterjee, Utkarsh Jain, Nidhi Chauhan

Bioorganic Chemistry · 2024-04 · 145 · 107151

DOI: 10.1016/j.bioorg.2024.107151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2024-04. Verfasst von Aditya Mulukutla und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences and Technology, UPES, Dehradun 248007, Uttarakhand, India. Hauptthemen laut MEDLINE: Antimicrobial Cationic Peptides, Antimicrobial Peptides. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 177 Literaturangaben. Gefördert von: University of Petroleum and Energy Studies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) are a group of polypeptide chains that have the property to target and kill a myriad of microbial organisms including viruses, bacteria, protists, etc. The first discovered AMP was named gramicidin, an extract of aerobic soil bacteria. Further studies discovered that these peptides are present not only in prokaryotes but in eukaryotes as well. They play a vital role in human innate immunity and wound repair. Consequently, they have maintained a high level of intrigue among scientists in the field of immunology, especially so with the rise of antibiotic-resistant pathogens decreasing the reliability of antibiotics in healthcare. While AMPs have promising potential to substitute for common antibiotics, their use as effective replacements is barred by certain limitations. First, they have the potential to be cytotoxic to human cells. Second, they are unstable in the blood due to action by various proteolytic agents and ions that cause their degradation. This review provides an overview of the mechanism of AMPs, their limitations, and developments in recent years that provide techniques to overcome those limitations. We also discuss the advantages and drawbacks of AMPs as a replacement for antibiotics as compared to other alternatives such as synthetically modified bacteriophages, traditional medicine, and probiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial Cationic PeptidesAntimicrobial PeptidesHumansReproducibility of ResultsAnti-Bacterial AgentsBacteria

Stichwörter der Autor:innen

AntibacterialAntifungalAntimicrobial peptidesAntiviralImmunotherapy

Substanzen

Antimicrobial Cationic PeptidesAntimicrobial PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Health Sciences and Technology, UPES, Dehradun 248007, Uttarakhand, India.
  • School of Health Sciences and Technology, UPES, Dehradun 248007, Uttarakhand, India. Electronic address: nidhi.chauhan@ddn.upes.ac.in.

Förderung

  • University of Petroleum and Energy Studies

Zitieren

APA

Mulukutla, A., Shreshtha, R., Kumar Deb, V., Chatterjee, P., Jain, U., & Chauhan, N. (2024). Recent advances in antimicrobial peptide-based therapy. Bioorganic Chemistry, 145, 107151. https://doi.org/10.1016/j.bioorg.2024.107151

Vancouver

Mulukutla A, Shreshtha R, Kumar Deb V, Chatterjee P, Jain U, Chauhan N. Recent advances in antimicrobial peptide-based therapy. Bioorganic Chemistry. 2024;145:107151. doi:10.1016/j.bioorg.2024.107151

BibTeX
@article{Mulukutla2024,
  author = {Mulukutla, Aditya and Shreshtha, Romi and Kumar Deb, Vishal and Chatterjee, Pallabi and Jain, Utkarsh and Chauhan, Nidhi},
  title = {Recent advances in antimicrobial peptide-based therapy},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {145},
  pages = {107151},
  doi = {10.1016/j.bioorg.2024.107151}
}
Kostenlos starten →